S
ShanX Medtech
Biotech & Life Sciences · Eindhoven, Netherlands · Founded 2019
Provides innovative in-vitro diagnostic platforms to support optimal bacterial infection management MoreLess
ShanX Medtech BV (SXM, NL) is developing an ultra-rapid, direct-from-specimen Antibiotic Susceptibility Testing (AST) platform device for point of care use at any healthcare setting. The device uses FLORA, their proprietary fluorescent chemistry to monitor bacterial metabolism across a panel of antibiotics. Delivering lab-grade results in as fast as one hour, the device is a simple system that requires no pre-analytical steps with seconds in hands on time, seamlessly integrating into the workflows of any physician or (hospital) laboratory technician. SXM empowers healthcare providers to administer the correct antibiotic treatment from the very first time.
SXM thrives in a highly competitive market, and their innovative, ultra-rapid platform—proven to work directly from a variety of specimens—places them at the forefront of meeting the increasing demand for advanced medical technology. This positions them to play a crucial role in the fight against antimicrobial resistance.
Keywords: Healthcare, Medical Technology, Innovation, Health Outcomes, Healthcare Providers, Hospitals, Clinics, Advanced Medical Technology, Market Disruption.
Company overview
ShanX Medtech company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2019
- Headquarters
- Eindhoven, Netherlands
- Employees
- 17
- Open positions
- 1
- Dealroom signal
- 93.1
Valuation & funding
ShanX Medtech funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GRANT✓Other financing | Jan 2026 | $8.8M | — | European Commission | ↗ |
| SEED✓Equity / VC | Jan 2026 | $17M | $66M | BOM - Brabant Regional Development Agency · CbusineZ · NextGen Ventures · Borski Fund | ↗ |
| OtherOther financing | Oct 2024 | $4.8M | — | Undisclosed | — |
| SEEDEquity / VC | Aug 2022 | $2.9M | $12M | Undisclosed | ↗ |
| SEED✓Equity / VC | Dec 2021 | $220K | $880K | Brabant Startup Fund | ↗ |
| SPINOUT✓Other financing | Apr 2019 | Eindhoven University of Technology | — |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 18 |
| 2025 | 8 |
| 2024 | 3 |
| 2023 | 6 |
| 2022 | 4 |
| 2021 | 1 |
Growth signals
ShanX Medtech website traffic
Latest recorded traffic for ShanX Medtech is 1.1K monthly website visits, down 59.3% over the last three months. ShanX Medtech's team grew 112.5% over the past year.
Hiring
Open positions at ShanX Medtech
Current openings linked to this company in Dealroom.
Comparisons
ShanX Medtech compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
ShanX Medtech's talent
Source: Dealroom Talent Intelligence.
Investors
9 investors on ShanX Medtech's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where ShanX Medtech has talent and traffic
team presence
In the news
Latest news about ShanX Medtech
Recent press, funding announcements, and product moves mentioning ShanX Medtech — open to read from the original sources.
Market sentiment
What the market is saying about ShanX Medtech
An AI-synthesized read of the highest-engagement posts about ShanX Medtech on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See ShanX Medtech’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.